Aarti Pharmalabs, a company in the Pharmaceuticals industry, reported revenue of ₹610 crore and net profit of ₹71 crore for the September 2026 quarter.
Aarti Pharmalabs (NSE: AARTIPHARM) closed at ₹990.70 on 20 Nov 2026, up 39.0% over the past year. Its market capitalisation is ₹8,984 crore and it trades at 34.5 times earnings.
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.